Related Experiment Videos
[Von Hippel-Lindau syndrome]
Klinische Monatsblatter Fur Augenheilkunde
|June 1, 1984
Summary
Von Hippel-Lindau syndrome is an inherited disorder causing tumors and cysts in various organs. Early recognition by ophthalmologists is crucial for managing this polyneoplastic hereditary disease.
Area of Science:
- Genetics and Hereditary Diseases
- Neurology
- Oncology
Context:
- Von Hippel-Lindau (VHL) syndrome is an autosomal dominant genetic disorder.
- It involves the development of tumors and cysts in multiple organs, including the eyes, brain, kidneys, and pancreas.
- Historical observations trace back to the late 19th century, with key descriptions by Jackson, Magnus, and Czermak before Lindau's work.
Purpose:
- To describe the clinical manifestations and hereditary nature of Von Hippel-Lindau syndrome.
- To highlight the polyneoplastic and polyangiomatous characteristics of the disease.
- To emphasize the critical role of ophthalmologists in early diagnosis and family risk assessment.
Summary:
- VHL syndrome presents with retinal and central nervous system angiomas, alongside cystic and neoplastic growths in kidneys and pancreas (e.g., hypernephroma, pheochromocytoma).
- It is characterized as a polyneoplastic hereditary disease, affecting families with increased cancer risk.
- Ophthalmologists play a pivotal role in initial diagnosis through funduscopic examination.
Impact:
- Early identification of VHL syndrome enables timely medical intervention and management strategies.
- Understanding the syndrome's hereditary nature facilitates genetic counseling and screening for at-risk family members.
- This knowledge empowers ophthalmologists to be key players in the multidisciplinary care of VHL patients.